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Despite the advances in neonatal pulmonology in last decades,
neonatologists still encounter an acute pulmonary disease
mainly associated with respiratory distress syndrome (RDS)
and mechanical ventilation in very low birth weight infants
(VLBWI), known as pulmonary interstitial emphysema (PIE).1
As a formofair leak syndrome, PIE is deﬁnedas the presence of
entrapped air “bubbles” along the bronchovascular bundles
resulting from a dissection of the interstitial or perivascular
lung tissue. According to the distribution pattern and the time
of occurrence, PIE can be classiﬁed as local or diffuse and acute
or persistent.2 Pathophysiologically, the trapped gas progres-
sively impairs pulmonary gas exchange by compressing func-
tional lung tissue and reducing pulmonary blood ﬂow.3
Managementof consecutivehypoxemia and respiratory acido-
sis in PIE is challenging and may be aggravated by the devel-
opment of pneumomediastinum, pneumothorax, or
pneumopericardium.4 While older studies from the pre-sur-
factant era reported a high incidence of PIE (32%) in VLBWI
with RDS exposed to mechanical ventilation within the ﬁrst
5 days of life, more recent data suggest a lower incidence
(4.6%).5,6 Early surfactant administration and the increased
use of new ventilation modes may be attributable to this
considerable reduction in PIE in the very preterm popula-
tion.7,8Althoughclosely linkedtomechanicalventilation, early
emphysematic changes inVLBWImayoccur evenwith thesole
application of nasal continuous positive airway pressure
(CPAP).9 Due to the increased use of noninvasive ventilation
strategies and noninvasive surfactant administration techni-
ques, we would like to present an uncommon case of VLBW
twins who subsequently developed PIE during noninvasive
respiratory support. We further discuss the etiopathology,
potential preventive strategies, and the respiratory manage-
ment in established PIE.
Case Report
Female diamniotic dichorionic twins were born to a 34-year-
old ﬁrst gravida at 28 þ 5 weeks of gestational age by C-
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Abstract Early pulmonary interstitial emphysema in extreme preterm neonates is closely linked
with respiratory distress syndrome and exposure to mechanical ventilation. In severe
cases, maintaining adequate gas exchange aiming to avoid further lung damage and
other neonatal morbidities associated with systemic/pulmonary hypoperfusion, pro-
longed hypoxia, and respiratory acidosis can be challenging and requires in-depth
knowledge into the pathophysiology of the disease. Herein, we report on very low birth
weight twins who developed early pulmonary interstitial emphysema during non-
invasive respiratory support. We further review the current evidence from the
literature, speciﬁcally addressing on possible preventive measures and the respiratory
management options of this acute pulmonary disease in high-risk neonates.
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section following premature rupture of the membranes
(4 hours before delivery). Antenatal steroids were adminis-
tered 2 weeks prior to delivery. The pregnancy was compli-
cated by growth difference between the fetuses (selective
intrauterine growth retardation) and gestational diabetes.
There were no clinical symptoms, laboratory, or histological
signs of chorioamnionitis. Serologies were all protective. The
mother received an antibiotic course of Clindamycin for
1 week (vaginal swab specimen: Enterococcus faecalis,
Escherichia coli, Streptococcus agalactiae). The parents were
otherwise healthy.
Twin A. Apgar scores were 6 and 8 at 1 and 5 minutes,
respectively. Birth weight was 1350 g (50th–75th centile).
Delivery roommanagement (as per our local hospital protocol
for delivery room management of VLBWI) included nasal
intermittent positive pressure ventilation (NIPPV), (settings:
peak inspiratory pressure (PIP) 16 cm H2O, positive end
expiratory pressure (PEEP) 8 cmH2O, FiO2 (fraction of inspired
oxygen) 0.40, respiratory rate (RR) 40/min, inspiratory time
(Ti) 0.3 second, ﬂow restriction 101/min). Empiric antibiotic
treatment (ampicillin and gentamycin) was discontinued at
day of life (DOL) 5. Blood cultures remained sterile with
negative C reactive protein. Initially mild clinical symptoms
for respiratory distress were noted and treated with NIPPV
(nasal ﬂaring, grunting, mild subcostal retractions). The chest
X-ray (CXR) at 2 hours of age showedRDS grade I (►Fig. 1A). At
6 hours of age, the infant received less invasive surfactant
administration (120 mg Surfactant Curosurf suspension via 4
Frenchumbilicalveincatheter) for increasedworkofbreathing
(WOB) and high oxygen requirements (FiO2 0.50). Post-surfac-
tant, the infant remained stable on room air with nasal CPAP
support. At 18 hours of life, a left-sided mild diffuse PIE was
noted in the CXR (►Fig. 1B) which was treated with lateral
decubital positioning and PEEP level reduction. At DOL 3, FiO2
suddenly increased to 0.50 with moderate WOB. CXR then
revealed a ventral pneumothorax on the left side with mild
mediastinal shift to the right (►Fig. 1C), which was treated
conservatively with left-side down positioning not modifying
the respiratory support. FiO2 decreased to 0.30 with substan-
tial clinical improvement and stable hemodynamic conditions
Fig. 1 Anterior–posterior chest X-rays, ventilator settings, interventions, and blood gas results of twin A case. (A) Two hours after birth. RDS
picture grade I°. Ventilator settings: NIPPV-Mode, PIP 16 cm H2O, PEEP 7 cm H2O, RR 60/min, FiO2 0.21, Ti 0.3. Blood gas results (venous): pH
7.24, pCO2 56 mm Hg. (B) Eighteen hours of life. Left-sided diffuse pulmonary interstitial emphysema. Ventilator settings: NIPPV-Mode, PIP
16 cm H2O, PEEP 7 cm H2O, RR 60/min, FiO2 0.21. Infant was further switched to CPAP-Mode and PEEP further dropped down to 5 cm H2O. (C)
Forty-seven hours of life. Left-sided ventral pneumothorax (arrows), mild mediastinal shift to the right. Ventilator settings: CPAP-Mode, PEEP
7 cm H2O, FiO2 0.3. Blood gas results (venous) pH 7.2, pCO2 44 mm Hg. Abbreviations: CPAP, continuous positive airway pressure; FiO2, fraction
of inspired oxygen; NIPPV, noninvasive positive pressure ventilation; pCO2, partial pressure of oxygen; PEEP, positive end-expiratory pressure;
PIP, positive inspiratory pressure; RDS, respiratory distress syndrome; RR, respiratory rate; Ti, inspiratory time.
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throughout the active stage of PIE. At DOL 7, twin A was
transferred to the intermediate care unit on high-ﬂow nasal
cannula (ﬂow 61/min, room air). According to the National
Institutes of Health (NIH) deﬁnition, the infant did not meet
the criteria forBPDat36 weeksgestational age (aspernational
institute of health deﬁnition).10 Additional examination ﬁnd-
ings were intraventricular hemorrhage (unilateral, right side,
grade IV) and hyperbilirubinemia.
Twin B. Apgar scores were 7 at 1 and 9 at 5minutes of age.
Birth weight was 900 g (10th–25th centile). The infant was
stabilized in the delivery room with NIPPV (PIP 16 cm H2O,
PEEP 8 cmH2O, max. FiO2 0.40, Ti 0.3 second, ﬂow restriction
101/min). Birth weight was 900 g (10th–25th centile).
Empiric antibiotic therapywas started (ampicillin, gentamy-
cin) and discontinued after 5 days with negative blood
cultures and tracheal aspirates. At 3 hours of life, the CXR
demonstrated an RDS picture grade I (►Fig. 2A). The baby
remained stable on NIPPV during the ﬁrst 24 hours (PIP
14 cm H2O, PEEP 6 cm H2O, FiO2 0.21, Ti 0.3 second, RR of
60/min). At the second DOL, the twin required higher FiO2
during NIPPVand increasedWOB. The following CXR showed
a bilateral diffuse PIE (►Fig. 2B). Due to the progressive and
severe oxygenation disorder (FiO2 1.0) at 29 hours after
birth, the infant received noninvasive surfactant (120 mg
Surfactant Curosurf suspension via 4 French umbilical vein
catheter). After a short improvement period, the infant
deteriorated rapidly. At this stage, a tension pneumothorax
on the right side with diffuse PIE on the left was diagnosed
(►Fig. 2C) and emergency chest needling was performed
with a peripheral intravenous cannula (G 20, Vasoﬁx, Braun,
Germany). The infant was intubated and a chest tube (6
French Fuhrman, initial negative suction pressure –30 mm
Hg, further reduced to –10 mm Hg) was inserted into the
right hemithorax (►Fig. 2D) and the babywas stabilizedwith
conventional ventilation (synchronized intermittent man-
datory ventilation, PIP 13cm H2O, PEEP 4 cm H2O, FiO2 0.45,
RR 80/min, Ti 0.25). Due to a progressive respiratory acidosis
(pH 7.05, pCO2 91 mm Hg), high-frequency oscillatory ven-
tilation (HFOV) was initiated (►Fig. 2D). The neonate
remained hemodynamically stable throughout the entire
procedures and did not require any inotropic support.
Respiratory support was further weaned (mean airway
pressure 5 cm H2O, frequency 480/min, FiO2 0.28) with
improved ventilation (pH 7.25, pCO2 47 mm Hg). The baby
was eventually extubated to nasal CPAP (PEEP 5 cmH2O, FiO2
0.3), and the chest tube removed prior to extubation. At DOL
8, twin B was transferred to the intermediate care unit on
high-ﬂow nasal cannula (ﬂow 81/min, room air). The follow-
up CXR showed complete resolution of the interstitial
emphysema (►Fig. 2E). The infant developed a mild bronch-
opulmonary dysplasia (as per national institute of health
deﬁnition).10
Discussion
In our two patients, clinical and radiological appearance of
early PIE in VLBW twins with RDS occurred during exclusive
noninvasive respiratory support. RDS in preterm neonates is
a known risk factor for PIE, especially when treated with
mechanical ventilation and the use of very high PIPs.11
However, several authors report on the spontaneous evolu-
tion of PIE in preterm neonates even in the absence of
invasive ventilation, including a set of twin VLBWI.9,12–14
Prior to the development of PIE, all these cases reported in
the literature had clinical and radiological signs of RDS, but
were never treated with surfactant. Thus, it is unclear if
mechanical ventilation is the main driver in the etiology of
PIE or whether early PIE is rather the consequence of missed
or delayed surfactant administration. Understanding the
etiopathogenesis of this pulmonary disease is crucial and
may have important implications in the respiratorymanage-
ment of RDS and PIE in the preterm population. Anatomical
and functional airway characteristics in the early course of
RDS are different as compared with other pulmonary dis-
eases andmay predispose VLBW to the development of early
PIE. Ackermann et al hypothesized that in the surfactant
deﬁcient and structural immature lung, the compliance of
the terminal gas exchange structures (i.e., the saccular and
alveolar level) is reduced, while the airway compliance
remains normal.15 This is supported by Reynolds et al who
have shown that the terminal airways of deceased neonates
treated with positive pressure ventilation for RDS were
usually dilated, but the distal air sacculeswere not inﬂated.16
In the poorly recruited but ventilated lung, histology showed
marked dilatation lesions of the bronchiolar and alveolar
duct areas with the evidence of PIE in the lymphatic tissue
around the pulmonary arteries. These ﬁndings suggest that
the location of injury is the terminal conductive airway
rather than alveolar or saccular rupture.16 Considering the
above mentioned aspects, it seems conclusive that preven-
tive and therapeutic strategies to improve lung compliance
and reduce exposure to volutrauma, such as antenatal ster-
oids, early surfactant administration, and the use of volume
targeted ventilation modes in VLBW infants will eventually
decrease the incidence of PIE.1,7,8 Of interest, two large
studies assessing the effect of early CPAP, the COIN trial
and a trial conducted by Rojas et al, reported a higher
incidence of air leaks with the use of CPAP,6,17whereas other
trials (i.e., SUPPORT and CURPAP) with a similar design did
not ﬁnd this association.18,19 This might be explained by the
different FiO2-intervention thresholds for intubation and
surfactant administration (FiO2 > 0.6 in the COIN and Rojas
trial vs FiO2 > 0.4 in the SUPPORT and CURPAP study), where
increased FiO2 requirements may indicate progression and
severity of RDS. Results of a meta-analysis conﬁrmed that a
lower FiO2 threshold for surfactant administration (0.45)
decreased the incidence of air leaks in VLBWI.20 In our case
report, twin A received noninvasive surfactant administra-
tion at 6 hours of life for increased WOB and oxygen
requirements (FiO2 0.5). Despite the good clinical response
to surfactant, the infant developed unilateral PIE at 18 hours
of life. Twin B, however, had only mild clinical signs of RDS
with no additional oxygen requirements throughout theﬁrst
24 hours of life, but subsequently deteriorated with severe
bilateral diffuse PIE, consecutive pneumothorax, and the
need for mechanical ventilation. Noninvasive surfactant
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Fig. 2 Anterior–posterior chest X-rays, ventilator settings, interventions, and blood gas results of twin B case. (A) Two hours after birth. RDS
picture grade I°. Ventilator settings: NIPPV-Mode, PIP 14 cm H2O, PEEP 6 cm H2O, RR 60/min, FiO2 0.21, Ti 0.3. Blood gas results (venous): pH
7.34, pCO2 44mm Hg. (B) Twenty-six hours of life. Evolving bilateral and diffuse pulmonary interstitial emphysema. Ventilator settings: NIPPV-
Mode, PIP 16 cm H2O, PEEP 6 cm H2O, RR 60/min, FiO2 1.0, Ti 0.3. Blood gas results (venous): pH 7.22, pCO2 47 mm Hg. Infant received
noninvasive surfactant administration and was switched to CPAP-Mode with PEEP 4 cm H2O. (C) Thirty-two hours of life. Right-sided tension
pneumothorax (arrows) with mediastinal shifting to the left. Ventilator settings: CPAP-Mode, PEEP 4 cm H2O. Emergency chest-needling,
intubation and chest tube insertion was performed and infant switched to conventional ventilation mode: SIMV, PIP 13 cm H20, PEEP 4 cm H20,
FiO2 0.45, RR 80/min, Ti 0.25. Blood gas results (venous): pH 7.16, pCO2 63 mm Hg. (D) Seventy-seven hours of life. Intubated neonate with
adequately drained pneumothorax, apical resolving PIE, and residual cysts in the basal lung segments. Note compression of left lung resulted in
resolution of PIE on the left. Infant was switched to HFOV due to progressive respiratory acidosis (pH 7.05, pCO2 91 mm Hg) on conventional
ventilation. Ventilator settings: HFOV, mean airway pressure 8 cm H2O, frequency 480/min, FiO2 0.35. (E) At day of life 11. Complete resolution
of PIE. Ventilator settings: High-ﬂow nasal cannulas, ﬂow 81/min, FiO2 0.21. Abbreviations: CPAP, continuous positive airway pressure; FiO2,
fraction of inspired oxygen; HFOV, high frequency oscillation ventilation; NIPPV, noninvasive positive pressure ventilation; pCO2, partial pressure
of oxygen; PEEP, positive end-expiratory pressure; PIE, pulmonary interstitial emphysema; PIP, positive inspiratory pressure; RDS, respiratory
distress syndrome; RR, respiratory rate; SIMV, synchronized intermittent mandatory ventilation; Ti, inspiratory time.
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administration is increasingly used in VLBWI to avoid
mechanical ventilation and has been used in both twins in
our case report.21 In a recently conducted large multicenter
trial by Kribs et al, the use of noninvasive surfactant applica-
tion signiﬁcantly reduced the incidence of pneumothoraces
in a high-risk study population.22 Unfortunately, the authors
did not speciﬁcally address on the incidence of PIE or the
potential adverse event of unilateral surfactant administra-
tion, which might have occurred in twin A. We can only
speculate that earlier treatment with surfactant might have
prevented the development of PIE in our siblings. In fact,
surfactant treatment during active PIE with severe respira-
tory failure, as applied in twin B, is not evidence based and, if
anything, should be restricted to cases where other recom-
mended treatment options (i.e., high-frequency ventilation
modalities) are ineffective. With regard to the timing of
surfactant therapy in both twins, one could argue that using
the FiO2 as a single surrogate parameter for RDS severitymay
not adequately reﬂect the disease state and that the decision
to treat with surfactant should be based on physiologic
parameters (FiO2) and reliable clinical scoring systems for
RDS (i.e., Silverman score), as applied in the study by Kribs
et al22,23 Although the twin status and the uncommon
clinical course in both siblings may also point toward an
infectious/inﬂammatory cause for PIE development, we did
not ﬁnd any clinical, microbiological, or laboratory evidence
for chorioamnionitis or neonatal sepsis.24,25 Verma et al
found that in utero exposure to high doses of magnesium
sulfate (cumulative dose > 10 g) is an independent risk
factor for PIE in extremely low birth weight infants.26 In
our case, the mother did receive a lower cumulative dose of
magnesium sulfate (i.e., 5 g).
The administration of antenatal corticosteroids (ANCS) has
been shown to reduce the risk of morbidity and mortality for
preterm neonates. Meta-analyses have demonstrated a lower
risk of death, respiratory morbidity, intracranial hemorrhage,
and necrotizing enterocolitis.27 The timing of ANCS relative to
preterm birth appears to be crucialwith the greatest beneﬁt if
deliveryoccurs > 24hours and < 7days.28Beneﬁts regarding
the severity of RDSmay dissipate after an interval of > 7 days
between ANCS administration and birth, particularly infants
who received antenatal steroids > 14 days prior to delivery.29
In our twin case report, there was a delay between ANCS
administration and delivery of 14 days. Whether a second
course or a single booster of ANCS is beneﬁcial regarding the
risk and severity of RDS remains controversialwith conﬂicting
results reported from the literature but no signiﬁcant harm in
early childhood either.30,31 Although the meta-analysis
showed less need for mechanical ventilation in infants treated
with ANCS, the incidence of any air leak syndromes was not
signiﬁcantly reduced.27
Respiratory management of established PIE is challenging
and may include noninvasive and/or invasive ventilation
strategies. In our view, stable respiratory and hemodynamic
conditions justiﬁed a conservative management approach
(nasal CPAP and lateral decubitus positioning) in twin A,
while twin B required distinct intensive care support due to
the disease progression with tension pneumothorax and
signiﬁcant respiratory acidosis. Initially, the ventilation
strategy in sibling B comprised of a reduction inmean airway
pressure by dropping PEEP, PIP, shortening the Ti, and high
RR (►Fig. 2C). In theory, this should allow the interstitial air
to escape and further avoid gas trapping while maintaining
adequate expansion of the distal airways.32However, clinical
data regarding the potential beneﬁts or harm of this
approach are restricted to successful case series.32–34 Pro-
gressive respiratory acidosis in twin B forced us to switch the
baby to HFOV with a rate of 480/min. Measures of oxygena-
tion and ventilation quickly improved thereafter (►Fig. 2D).
HFOV has been proposed as a “lung protective” ventilation
strategy in preterm neonates because it offers the beneﬁt of
adequate gas exchange using very low tidal volumes and
lower mean airway pressures.35 In a large prospective case
series, Squires et al reported on 19 cases of VLBWI with PIE
(14 bilateral, 5 unilateral, respectively) that were managed
with HFOV using very low oscillatory frequency of 300 to
360/min for a minimum period of 24 hours.36 After transi-
tion to HFOV, a rapid and sustained improvement in oxyge-
nation and ventilationwas noted, particularly in the bilateral
PIE group. Outcomes reported in the study were promising
with a survival rate of 71% in the bilateral and 100% in the
unilateral group. However, 90% of the survivors in the
bilateral and 80% in the unilateral group were diagnosed
with bronchopulmonary dysplasia. In our case report in twin
B, we did not go down as lowas a HFOV frequency of 480/min
by reason of satisfying physiological responses at this rate.
High frequency jet ventilation (HFJV), another mode of high
frequency ventilation, appears to be the most promising
ventilation strategy in preterm neonates with PIE. HFJV
typically applies very short jet pulses (Ti 0.02–0.03, rate of
400–450/min), superimposed on a low continuous distend-
ing pressure, resulting in a prolonged expiratory cycle which
maymost effectively interrupt the pathogenesis of PIE.37One
randomized controlled multicenter trial in the early 90s
compared HFJV versus rapid rate conventional ventilation
in preterm infantswith active PIE and found some beneﬁts of
HFJV regarding the resolution of PIE for >24 hours and
radiographic improvement with no signiﬁcant differences
in the incidence of bronchopulmonary dysplasia or intraven-
tricular hemorrhage.38 Notably, when survival resulting
from rescue by the alternate therapy was excluded, survival
rates were signiﬁcantly higher in the HFJV group (64.9% vs
47.1%). Nevertheless, lack of availability of the HFJ ventilator
limits its use, particularly in the Europe.
Further treatment options for PIE with very limited evi-
dence and variable outcomes include selective main bron-
chial intubation for unilateral diseases and even more
invasively, the creation of an artiﬁcial pneumothorax.39,40
Treatment of unilateral PIE by the use of Swan-Ganz catheter
in unilateral PIE has also been successfully used and reported
in the literature.41
Conclusion
Our case of PIE development during noninvasive ventilation
in VLBW twins is in linewith several other reports of preterm
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infantswho have been treatedwith CPAP. The administration
of antenatal steroids, invasive, and/or noninvasive surfactant
treatment in the early course of RDS and the use of lung
protective ventilation strategies (volume targeted ventila-
tion)may decrease the incidence of PIE in high-risk neonates.
Ventilation strategies during active PIE include noninvasive
respiratory support in stable selected cases, while distinct
clinical respiratory instability should be managed using
either conventional ventilation with supraphysiological
RRs and short Tis, HFOVwith lower rates or HFJV, if available.
Since CPAP/NIPPVand noninvasive surfactant administration
is increasingly used in neonatal intensive care, clinical
awareness for PIE should be paid to VLBW neonates with
deteriorating respiratory conditions undergoing noninvasive
respiratory support. We would further encourage investiga-
tors to speciﬁcally report on the incidence of PIE in future
clinical trials dealing with neonatal pulmonary short- and
long-term outcomes.
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